Ayse Hande Tarikogullari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ayse Hande Tarikogullari has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Merve Saylam
İzmir Katip Çelebi University Faculty of Pharmacy, Department of Pharmaceutical Chemistry, İzmir, Türkiye
4 shared publications - Sinem Yilmaz
Department of Biotechnology, Graduate School of Natural and Applied Sciences, Ege University
3 shared publications - Petek Ballar Kirmizibayrak
Department of Biochemistry, Faculty of Pharmacy, Ege University, İzmir, Türkiye
2 shared publications - Sulunay Parlar
Ege University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry
2 shared publications - Vildan Alptüzün
Department of Pharmaceutical Chemistry Faculty of Pharmacy, Ege University Izmir Turkey
2 shared publications - Zeynep Soyer
Ege Universitesi
2 shared publications
Latest Publications
- Open Access
- 13 February 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (1) , 1-9
3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives: Design, Synthesis and Neuroprotectivity Potential Against 6-OHDA Induced Neurotoxicity Model
Excessive amounts of neuroapoptosis are the underlying cause of neurodegenerative diseases. Bax is a pro-apoptotic member of the B-cell lymphoma-2 family that activates caspases which are the members of the cysteine protease family that play a significant role in the initiation and execution phases of apoptosis. The aim of this study was to design and synthesize a group of N-propananilide derivatives bearing pyrazole or 1,2,4-triazole ring were designed and synthesized to analyze the neuroprotectivity potential against 6-hydroxy-dopamine (6-OHDA). Four compounds possessed protectivity at lower doses were subjected to further studies on caspase-3 and Bax pathway. Designed compounds were synthesized by reacting 1H-pyrazole or 1H-1,2,4-triazole with propananilide intermediates in Dimethylformamide. The neuroprotective activity of the title compounds was analyzed against 6-OHDA-6-OHDA-induced neurotoxicity model. Then, caspase-3 and Bax levels were determined for the selected compounds by Western blot study. All twelve 3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives possessed neuroprotectivity against the 6-OHDA-induced neurotoxicity model (p≤0.05, **p≤0.001, ***p≤0.005). Compounds 7, 10, 11, and 12 were found to be more active at lower doses. They were subjected to further studies and the results revealed that their protecting activity arose from the decreasing levels of Bax, one of the pro-apoptotic proteins, and c expression levels and caspase-3 proteins. All designed and synthesized derivatives possessed neuroprotectivity against 6-OHDA-induced neurotoxicity in the SH-SY5Y cell line and compounds 7, 10, 11, and 12 revealed that their neuroprotectivity originated from the decreasing Bax expression levels and caspase-3 activation.
- 13 February 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (1) , 1-9
Open Access3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives: Design, Synthesis and Neuroprotectivity Potential Against 6-OHDA Induced Neurotoxicity Model
Excessive amounts of neuroapoptosis are the underlying cause of neurodegenerative diseases. Bax is a pro-apoptotic member of the B-cell lymphoma-2 family that activates caspases which are the members of the cysteine protease family that play a significant role in the initiation and execution phases of apoptosis. The aim of this study was to design and synthesize a group of N-propananilide derivatives bearing pyrazole or 1,2,4-triazole ring were designed and synthesized to analyze the neuroprotectivity potential against 6-hydroxy-dopamine (6-OHDA). Four compounds possessed protectivity at lower doses were subjected to further studies on caspase-3 and Bax pathway. Designed compounds were synthesized by reacting 1H-pyrazole or 1H-1,2,4-triazole with propananilide intermediates in Dimethylformamide. The neuroprotective activity of the title compounds was analyzed against 6-OHDA-6-OHDA-induced neurotoxicity model. Then, caspase-3 and Bax levels were determined for the selected compounds by Western blot study. All twelve 3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives possessed neuroprotectivity against the 6-OHDA-induced neurotoxicity model (p≤0.05, **p≤0.001, ***p≤0.005). Compounds 7, 10, 11, and 12 were found to be more active at lower doses. They were subjected to further studies and the results revealed that their protecting activity arose from the decreasing levels of Bax, one of the pro-apoptotic proteins, and c expression levels and caspase-3 proteins. All designed and synthesized derivatives possessed neuroprotectivity against 6-OHDA-induced neurotoxicity in the SH-SY5Y cell line and compounds 7, 10, 11, and 12 revealed that their neuroprotectivity originated from the decreasing Bax expression levels and caspase-3 activation.
- 6 January 2022
- Published by ACG Publications in Bioorganic and Medicinal Chemistry Reports
- Vol. 4 (2) , 1-5
Neuroprotective activity studies of some phenylacetamide derivatives bearing 1H-pyrazole or 1H-1,2,4-triazole
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases are one of the most studied diseases in health sciences. Although each of them has their own mechanisms and outcomes, they share molecular mechanisms like oxidative stress which plays the key role in neurodegeneration. Therefore, alleviating the oxidative stress and improving the antioxidant defense capacity of the brain tissue helps to reduce the progression of neurotoxicity in neurodegenerative diseases including the Alzheimer’s disease. In this regard, we have studied the neuroprotective activity of the compounds that were determined as the most active derivatives against AChE enzyme in our previous study. The results revealed that Compounds 3 and 4 restore the cell viability especially at lower doses, hence, these two molecules may be a promising lead for further studies with their neuroprotectivity potential and AChE inhibitory activity.
- 6 January 2022
- Published by ACG Publications in Bioorganic and Medicinal Chemistry Reports
- Vol. 4 (2) , 1-5
Neuroprotective activity studies of some phenylacetamide derivatives bearing 1H-pyrazole or 1H-1,2,4-triazole
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases are one of the most studied diseases in health sciences. Although each of them has their own mechanisms and outcomes, they share molecular mechanisms like oxidative stress which plays the key role in neurodegeneration. Therefore, alleviating the oxidative stress and improving the antioxidant defense capacity of the brain tissue helps to reduce the progression of neurotoxicity in neurodegenerative diseases including the Alzheimer’s disease. In this regard, we have studied the neuroprotective activity of the compounds that were determined as the most active derivatives against AChE enzyme in our previous study. The results revealed that Compounds 3 and 4 restore the cell viability especially at lower doses, hence, these two molecules may be a promising lead for further studies with their neuroprotectivity potential and AChE inhibitory activity.
- 1 January 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 209, 112890
Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors
- 1 January 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 209, 112890
Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors
- Open Access
- 1 October 2015
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 20 (1) , 21-27-21
Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole
Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole
- 1 October 2015
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 20 (1) , 21-27-21
Open AccessSynthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole
Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole